Aggregate data meta‐analysis with time‐to‐event outcomes
Citations Over TimeTop 10% of 2002 papers
Abstract
In a meta-analysis of randomized controlled trials with time-to-event outcomes, an aggregate data approach may be required for some or all included studies. Variation in the reporting of survival analyses in journals suggests that no single method for extracting the log(hazard ratio) estimate will suffice. Methods are described which improve upon a previously proposed method for estimating the log(HR) from survival curves. These methods extend to life-tables. In the situation where the treatment effect varies over time and the trials in the meta-analysis have different lengths of follow-up, heterogeneity may be evident. In order to assess whether the hazard ratio changes with time, several tests are proposed and compared. A cohort study comparing life expectancy of males and females with cerebral palsy and a systematic review of five trials comparing two anti-epileptic drugs, carbamazepine and sodium valproate, are used for illustration.
Related Papers
- → Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries(2016)105 cited
- → What happened to life expectancy in Spain in the 1980s?(1997)18 cited
- → THE ASSESSMENT OF PRIORITIES FOR INCREASING LIFE EXPECTANCY IN RUSSIA(2014)
- → Life expectancy and lifespan inequality: a perfect linear correlation? Analysis of the relationship with a particular emphasis on the case of countries going through the life expectancy stagnation period(2020)
- Healthy Life Expectancy and Health Gains in Cardiovascular Diseases Management in Korea(2012)